CIK 0001285550 · Non-accelerated filer<br>Smaller reporting company
ClearPoint Neuro, Inc.
Sign in to watch- Ticker
- CLPT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582394628
- Phone
- 9499006833
- Business address
- 120 S. SIERRA AVENUE, SUITE 100, SOLANA BEACH, CA, 92075
- Former names
- MRI INTERVENTIONS, INC., SURGIVISION INC, SURGI VISION INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-03 | D'Alessandro Danilo Chief Financial Officer | Option exercise | +10,332 | 80,662 | ||
| 2026-03-03 | D'Alessandro Danilo Chief Financial Officer | Shares withheld for taxes | −5,257 | $8.84 | $46K | 75,405 |
| 2026-03-03 | D'Alessandro Danilo Chief Financial Officer | Option exercise · Restricted Stock Units | −10,332 | 41,328 | ||
| 2026-03-03 | STIGALL L. JEREMY Chief Business Officer | Option exercise | +8,856 | 81,212 | ||
| 2026-03-03 | STIGALL L. JEREMY Chief Business Officer | Shares withheld for taxes | −4,506 | $8.84 | $40K | 76,706 |
| 2026-03-03 | STIGALL L. JEREMY Chief Business Officer | Option exercise · Restricted Stock Units | −8,856 | 35,424 | ||
| 2026-03-03 | SABRA MAZIN Chief Operating Officer | Option exercise | +6,642 | 51,112 | ||
| 2026-03-03 | SABRA MAZIN Chief Operating Officer | Shares withheld for taxes | −3,380 | $8.84 | $30K | 47,732 |
| 2026-03-03 | SABRA MAZIN Chief Operating Officer | Option exercise · Restricted Stock Units | −6,642 | 26,568 | ||
| 2026-02-25 | BURNETT JOSEPH CEO and President | Sale 10b5-1 | −19,951 | $15.17 | $303K | 193,231 |
| 2026-02-17 | SABRA MAZIN Chief Operating Officer | Grant or award · Restricted Stock Units | +36,818 | 36,818 | ||
| 2026-02-17 | STIGALL L. JEREMY Chief Business Officer | Grant or award · Restricted Stock Units | +51,546 | 51,546 | ||
| 2026-02-17 | D'Alessandro Danilo Chief Financial Officer | Grant or award · Restricted Stock Units | +66,273 | 66,273 | ||
| 2026-02-17 | BURNETT JOSEPH CEO and President | Grant or award · Restricted Stock Units | +147,275 | 147,275 | ||
| 2026-01-26 | BURNETT JOSEPH CEO and President | Sale 10b5-1 | −2,943 | $15.57 | $46K | 214,116 |
| 2026-01-09 | BURNETT JOSEPH CEO and President | Option exercise 10b5-1 | +20,000 | $2.50 | $50K | 31,565 |
| 2026-01-09 | BURNETT JOSEPH CEO and President | Sale 10b5-1 | −20,000 | $16.12 | $322K | 11,565 |
| 2026-01-09 | BURNETT JOSEPH CEO and President | Option exercise · Stock Options (right to buy) 10b5-1 | −20,000 | 330,000 | ||
| 2026-01-02 | Richards Timothy T. Director | Grant or award | +884 | $13.68 | $12K | 79,754 |
| 2026-01-02 | Girin Pascal E R Director | Grant or award | +502 | $13.68 | $7K | 97,451 |
Page 5 of 15 · 296 trades